XHKG
2158
Market cap783mUSD
May 16, Last price
5.77HKD
1D
-1.03%
1Q
-27.88%
IPO
-90.98%
Name
Yidu Tech Inc
Chart & Performance
P/E
—
P/S
7.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.12%
Rev. gr., 5y
51.23%
Revenues
807m
+0.30%
Net income
-195m
L-68.96%
CFO
-326m
L-8.58%
Earnings
Jun 25, 2025
Profile
Yidu Tech Inc. provides healthcare solutions built on big data and artificial intelligence technologies in Mainland China, Brunei, and internationally. The company operates through Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and Others segments. The Big Data Platform and Solutions segment offers data intelligence platforms and data analytics-driven solutions to hospitals, other healthcare institutions, regulators, and policy makers. This segment also provides applications and solutions to hospitals focusing on research, clinical diagnosis and treatment, and hospital operations management; DPAP/Eywa platforms for hospitals and medical institutions; and intelligent research and clinical and management solutions to medical customers. The Life Sciences Solutions segment offers analytics-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech, medical device, and other companies. The Health Management Platform and Solutions segment provides health management platform application and solution services; and insurance technology and solutions to insurance companies, agencies, and related regulators and policy makers. This segment also engages in the distribution of insurance companies products; and sale of pharmaceutical products and related hardware and other services. The Others segment is involved in the sale of computer hardware. The company also engages in the sale of medical devices; insurance brokerage activities; and medical and computer technology development activities. Yidu Tech Inc. was incorporated in 2014 and is headquartered in Beijing, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | |
| Income | |||||||
Revenues | 807,076 0.30% | 804,700 -34.96% | |||||
Cost of revenue | 1,080,767 | 1,376,342 | |||||
Unusual Expense (Income) | |||||||
NOPBT | (273,691) | (571,642) | |||||
NOPBT Margin | |||||||
Operating Taxes | 49 | 3,422 | |||||
Tax Rate | |||||||
NOPAT | (273,740) | (575,064) | |||||
Net income | (194,944) -68.96% | (627,966) -17.62% | |||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 6,280 | 5,465 | |||||
BB yield | -0.15% | -0.08% | |||||
| Debt | |||||||
Debt current | 88,786 | 9,538 | |||||
Long-term debt | 21,616 | 18,718 | |||||
Deferred revenue | 71,295 | 79,761 | |||||
Other long-term liabilities | 79,761 | ||||||
Net debt | (1,517,797) | (3,992,894) | |||||
| Cash flow | |||||||
Cash from operating activities | (326,383) | (357,013) | |||||
CAPEX | (39,233) | (17,588) | |||||
Cash from investing activities | 466,903 | (2,340,259) | |||||
Cash from financing activities | 82,208 | 361,455 | |||||
FCF | (134,558) | (653,518) | |||||
| Balance | |||||||
Cash | 3,703,563 | 3,752,243 | |||||
Long term investments | (2,075,364) | 268,907 | |||||
Excess cash | 1,587,845 | 3,980,915 | |||||
Stockholders' equity | (7,904,279) | (7,684,277) | |||||
Invested Capital | 12,162,768 | 12,002,367 | |||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | 1,051,620 | 995,204 | |||||
Price | 4.01 -45.22% | 7.32 -25.23% | |||||
Market cap | 4,216,996 -42.11% | 7,284,893 -22.31% | |||||
EV | 2,768,321 | 3,365,786 | |||||
EBITDA | (226,577) | (530,872) | |||||
EV/EBITDA | |||||||
Interest | 3,311 | 2,611 | |||||
Interest/NOPBT | |||||||